Angiotensinogen M235T polymorphism is associated with plasma angiotensinogen and cardiovascular disease

American Heart Journal

Volumn 137, Issue 4 I, 1999, Pages 698-705

  Winkelmann, B R ^a   Russ, A P ^a   Nauck, M ^a   Klein, B ^a   Bohm, B O ^a   Maier, V ^a   Zotz, R ^a   Matheis, G ^a   Wolf, A ^a   Wieland, H ^a   Gross, W ^a   Galton, D J ^a   Marz, W ^a  

^a KLINIKUM LUDWIGSHAFEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSINOGEN; APOLIPOPROTEIN B; GLUCOSE;

ADULT; AGED; ALLELISM; ANGIOCARDIOGRAPHY; ARTICLE; CARDIOVASCULAR DISEASE; CONTROLLED STUDY; CORONARY ARTERY ATHEROSCLEROSIS; CORONARY ARTERY DISEASE; DIASTOLIC BLOOD PRESSURE; DISEASE ASSOCIATION; DNA POLYMORPHISM; GENETIC ANALYSIS; GENETIC PREDISPOSITION; HEART INFARCTION; HOMOZYGOSITY; HUMAN; MAJOR CLINICAL STUDY; MALE; PATHOGENESIS; PRIORITY JOURNAL; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; RISK FACTOR; THROMBOSIS;

EID: 0032915912     PISSN: 00028703     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-8703(99)70226-7     Document Type: Article

References (55)

1. Corvol P, Jeunemaitre X, Charru A, Soubrier F. Genetic aspects of the renin-angiotensin system. In: Robertson JIS, Nicholls MG, editors. The renin-angiotensin system, vol I. New York: Mosby; 1993 p 3.1-3.10.
2. Caulfield M, Lavender P, Farrall M, et al. Linkage of the angiotensinogen gene to essential hypertension. N Engl J Med 1994;330:1629-33.
3. Jeunemaitre X, Soubrier F, Kotelevtsev YV, et al. Molecular basis of human hypertension: role of angiotensinogen. Cell 1992;71:169-80.
4. Chrostowska M, Narkiewicz K, Bigda J, et al. Ambulatory blood pressure is related to the polymorphism of the angiotensin I-converting enzyme gene in normotensives with parental history of hypertension [abstract]. Eur Heart J 1996;17(suppl):129.
5. Mattu RK, Needham EWA, Galton DJ, et al. A DNA variant at the angiotensin-converting enzyme gene locus associates with coronary artery disease in the Caerphilly Heart Study. Circulation 1995;91:270-4.
6. Cambien F, Poirier O, Lecerf L, et al. Deletion polymorphism in the gene for angiotensin-converting enzyme is a potent risk factor for myocardial infarction. Nature 1992;359:641-4.
7. Katsuya T, Koike G, Yee TW, et al. Association of angiotensin gene T235 variant with increased risk of coronary heart disease. Lancet 1995;345:1600-3.
8. Winkelmann BR, Nauck M, Klein B, et al. Deletion polymorphism of the angiotensin I-converting enzyme gene is associated with increased plasma angiotensin-converting enzyme activity but not with increased risk for myocardial infarction and coronary artery disease. Ann Intern Med 1996;125:19-25.
9. Agerholm-Larsen B, Nordestgaard BG, Steffensen R, et al. ACE gene polymorphism: ischemic heart disease and longevity in 10150 individuals: a case-referent and retrospective cohort study based on the Copenhagen City Heart Study. Circulation 1997;95:2358-67.
10. Jeunemaitre X, Ledru F, Battaglia S, et al. Genetic polymorphisms of the renin-angiotensin system and angiographic extent and severity of coronary artery disease: the CORGENE study. Hum Genet 1997;99:66-73.
11. Kunz R, Kreutz R, Beige J, et al. Association between the angiotensinogen 235T-variant and essential hypertension in whites: a systematic review and methodological appraisal. Hypertension 1997;30:1331-7.
12. Bloem LJ, Manatunga AK, Tewsbury DA, et al. The serum angiotensinogen concentration and variants of the angiotensinogen gene in white and black children. J Clin Invest 1995;95:948-53.
13. 235→Thr variant on blood pressure and other cardiovascular risk factors in two Japanese populations. J Hypertens 1995;13:717-22.
14. Kamitani A, Rakugi H, Higaki J, et al. Association analysis of a polymorphism of the angiotensinogen gene with essential hypertension in Japanese. J Hum Hypertens 1994;8:521-4.
15. Hata A, Mamikawa C, Sasaki M, et al. Angiotensinogen as a risk factor for essential hypertension in Japan. J Clin Invest 1994;93:1285-7.
16. Johnson AG, Simons LA, Friedlander Y, et al. Polymorphism of the angiotensinogen, but not the angiotensin converting enzyme gene predicts hypertension in the elderly. J Hypertens 1996;14:1061-5.
17. Schmidt S, Sharma AM, Zilch O, et al. Association of M235T variant of the angiotensinogen gene with familial hypertension of early onset. Nephrol Dial Transplant 1995;10:1145-8.
18. Iwai N, Shimoike H, Ohmichi N, et al. Angiotensinogen gene and blood pressure in the Japanese population. Hypertension 1995;25[part 2]:668-93.
19. Jeunemaire X, Charru A, Chatellier G, et al. M235T variant of the human angiotensinogen gene in unselected hypertensive patients. J Hypertens 1993;11(suppl 5):S80-1.
20. Bloem LJ, Foroud TM, Ambrosius WT, et al. Association of the angiotensinogen gene to serum angiotensinogen in blacks and whites. Hypertension 1997;29:1078-82.
21. Schunkert H, Hense H-W, Gimenez-Roqueplo A, et al. The angiotensinogen T235 variant and the use of antihypertensive drugs in a population-based cohort. Hypertension 1997;29:628-33.
22. Hegele RA, Harris SB, Hanley AJG, et al. Angiotensinogen gene variation associated with variation in blood pressure in aboriginal Canadians. Hypertension 1997;29:1073-7.
23. Kamitani A, Rakugi H, Higaki J, et al. Enhanced predictability of myocardial infarction in Japanese by combined genotype analysis. Hypertension 1995;25:950-3.
24. Tiret L, Ricard S, Poirier O, et al. Genetic variation at the angiotensinogen locus in relation to high blood pressure and myocardial infarction: the ECTIM study. J Hypertens 1995;13:311-7.
25. Hegele RA, Brunt JH, Connelly PW. A polymorphism of the angiotensinogen gene associated with variation in blood pressure in a genetic isolate. Circulation 1994;90:2207-12.
26. Hingorani AD, Sharma P, Jia H, et al. Blood pressure and the M235T polymorphism of the angiotensinogen gene. Hypertension 1996; 28:907-11.
27. 235→Thr variant of angiotensinogen gene in severe familial hypertension. Biochem Biophys Res Commun 1993;197:833-9.
28. Yamakawa-Kobayashi K, Arinami T, Hamaguchi H. Absence of association of angiotensinogen gene T235 allele with increased risk of coronary artery disease in Japanese [letter]. Lancet 1995;346:516.
29. Caulfield M, Lavender P, Newell-Price J, et al. Linkage of the angiotensinogen gene locus to human essential hypertension in African Caribbeans. J Clin Invest 1995;96:687-92.
30. Fornage M, Turner ST, Sing CF, et al. Variation at the M235T locus of the angiotensinogen gene and essential hypertension: a population-based case-control study from Rochester, Minnesota. Hum Genet 1995;96:295-300.
31. Schmitz C, Berenson GS, Wattigney WA, et al. The M235T and T174M variants of the angiotensinogen gene show no association with blood pressure in white and black young adults [abstract]. J Hypertens 1996;14(suppl 1):S34.
32. Bigda J, Narkiewicz K, Chrostowska M, et al. Ambulatory blood pressure is not related to genetic variation at the angiotensinogen locus in normotensives [abstract]. J Hypertens 1996;14(suppl 1):S302.
33. Beige J, Zilch O, Hohenbleicher H, et al. Genetic variants of the renin-angiotensin system and ambulatory blood pressure in essential hypertension. J Hypertens 1997;15:503-8.
34. Ringel J, Beige J, Kunz R, et al. Genetic variants of the reninangiotensin system, diabetic nephropathy and hypertension. Diabetologia 1997;40:193-9.
35. Ishigami T, Umemura S, Iwamoto T, et al. Molecular variant of angiotensinogen gene is associated with coronary atherosclerosis. Circulation 1995;91:951-4.
36. Ohmichi N, Iwai N, Nakamura Y. Are the genotypes of angiotensin converting enzyme and angiotensinogen gene the risk factors of ischemic heart disease [abstract]? In: Abstracts Submitted to the Council on Arteriosclerosis for the 68th Scientific Sessions of the American Heart Association (but not presented). 1995. p 62.
37. Austen WG, Edwandg JE, Frye RL, et al. A reporting system on patients evaluated for coronary artery disease: report of the ad hoc committee for grading of coronary artery disease. Circulation 1975;50(suppl 5):7-40.
38. 235→Thr allele of the human angiotensinogen gene. Hum Mol Genet 1993;2:609-10.
39. Gould AB, Green B. Kinetics of the human renin and human renin substrate reaction. Cardiovasc Res 1971;5:86-9.
40. Eggena P, Barrett JD. Regulation and functional consequences of angiotensinogen gene expression. J Hypertens 1992;10:1307-11.
41. Kim H-S, Krege JH, Kluckman KD, et al. Genetic control of blood pressure and the angiotensinogen locus. Proc Natl Acad Sci U S A 1995;92:2735-9.
42. Takimoto E, Ishida J, Sugiyama F, et al. Hypertension induced in pregnant mice by placental and maternal angiotensinogen. Science 1996;274:995-8.
43. Tanimoto K, Sugiyama F, Goto Y, et al. Angiotensinogen-deficient mice with hypotension. J Biol Chem 1994;269:31334-7.
44. Philips MI, Wielbo D, Gyurko R. Antisense inhibition of hypertension: a new strategy for renin-angiotensin candidate genes. Kidney Int 1994;46:1554-6.
45. Krege JH, Kim H-S, Moyer JS, et al. Angiotensin-converting enzyme gene mutations, blood pressures, and cardiovascular homeostasis. Hypertension 1997;29[part 2]:150-157.
46. Walker WG, Whelton PK, Saito H, et al. Relation between blood pressure and renin, renin substrate, angiotensin II, aldosterone and urinary sodium and potassium in 574 ambulatory subjects. Hypertension 1979;1:287-91.
47. Watt GCM, Harrap SB, Foy CJW, et al. Abnormalities of glucocorticoid metabolism and the renin-angiotensin system: a four-corners approach to the identification of genetic determinants of blood pressure. J Hypertens 1992;10:473-82.
48. Hunt SC, Cook NR, Oberman A, et al. Is hypertension prevention by sodium reduction related to angiotensinogen genotype? The trials of hypertension prevention study, phase II [abstract]. Circulation 1997;96(suppl I):437.
49. Kurtz TW. Genetics of essential hypertension. Am J Med 1993;94:77-84.
50. Lifton RP. Molecular genetics of human hypertension. In: Mockrin SC. Molecular genetics and gene therapy of cardiovascular disease. New York: Marcel Dekker; 1996. p 111-33.
51. Mongeau J-G, Biron P, Sing CF. The influence of genetics and household environments upon the variability of blood pressure: the Montreal adoption study. Clin Exp Hypertens 1986;8:653-60.
52. Sealey JE, Gerten-Banes J, Laragh JH. The renin system: variations in man measured by radioimmuno- or bioassay. Kidney Int 1972;1:240-53.
53. Brasier AR, Li J. Mechanisms for inducible control of angiotensinogen gene transcription. Hypertension 1996;27[part 2]:465-75.
54. Brasier AR, Li J, Wimbish KA. Tumor necrosis factor activates angiotensinogen gene expression by the rel A transactivator. Hypertension 1996;27:1009-17.
55. Brand E, Chatelain N, Keavney B, et al. Evaluation of the angiotensinogen locus in human essential hypertension. Hypertension 1998; 31:725-9.